Position in UTHR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,138,603
+$347,211 QoQ
Shares Held
3,947
+30.7% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#362
of 870 holders
Holding Since
Mar 2020
8 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026FIL Ltd holds $565,763,475 across 9 Drug Manufacturers - Specialty & Generic names. UTHR ranks #6 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
5,381,783 | $386,734,925 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,752,506 | $127,134,902 | |
| 3 | VTRS |
Viatris Inc
|
2,118,598 | $33,643,336 | |
| 4 | LNTH |
Lantheus Holdings, Inc.
|
114,279 | $12,678,112 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
92,207 | $2,269,214 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
3,947 | $2,138,603 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
6,655 | $1,121,633 | |
| 8 | HLN |
Haleon plc
|
4,582 | $42,750 |
All Filings in UTHR
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,138,603 | 3,947 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $1,791,392 | 3,021 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $6,066,749 | 12,451 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $315,245 | 752 | Shares | Defined | 2025-11-13 | |
| 2024-09-30 | $441,128 | 1,231 | Shares | Defined | 2024-11-13 | |
| 2020-09-30 | $11,312 | 112 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $13,552 | 112 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $10,620 | 112 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||